Lakewood-Amedex backs PASTEUR Act, plans Phase 2 trial for Nu-3

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. ACN
3. FFAI
4. STI
5. MCD
6. PAA
7. PAGP
8. WBD
9. FAN
10. COHR

Go back to Lakewood-Amedex backs PASTEUR Act, plans Phase 2 trial for Nu-3
(NASDAQ: LABT) Delayed: 1.99 --0 (-0%)
Previous Close $1.99    52 Week High $ 
Open $1.99    52 Week Low $ 
Day High $1.99    P/E N/A 
Day Low $1.99    EPS $ 
Volume 4,506